These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34607441)

  • 1. V Spanish Consensus Conference on Helicobacter pylori infection treatment.
    Gisbert JP; Alcedo J; Amador J; Bujanda L; Calvet X; Castro-Fernández M; Fernández-Salazar L; Gené E; Lanas Á; Lucendo AJ; Molina-Infante J; Nyssen OP; Pérez-Aisa A; Puig I
    Rev Esp Enferm Dig; 2021 Oct; 113(10):. PubMed ID: 34607441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V Spanish Consensus Conference on Helicobacter pylori infection treatment.
    Gisbert JP; Alcedo J; Amador J; Bujanda L; Calvet X; Castro-Fernández M; Fernández-Salazar L; Gené E; Lanas Á; Lucendo AJ; Molina-Infante J; Nyssen OP; Pérez-Aisa A; Puig I
    Gastroenterol Hepatol; 2022 May; 45(5):392-417. PubMed ID: 34629204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IV Spanish Consensus Conference on Helicobacter pylori infection treatment.
    Gisbert JP; Molina-Infante J; Amador J; Bermejo F; Bujanda L; Calvet X; Castro-Fernández M; Cuadrado-Lavín A; Elizalde JI; Gene E; Gomollón F; Lanas Á; Martín de Argila C; Mearin F; Montoro M; Pérez-Aisa Á; Pérez-Trallero E; McNicholl AG
    Gastroenterol Hepatol; 2016 Dec; 39(10):697-721. PubMed ID: 27342080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
    Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
    Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.
    Fallone CA; Chiba N; van Zanten SV; Fischbach L; Gisbert JP; Hunt RH; Jones NL; Render C; Leontiadis GI; Moayyedi P; Marshall JK
    Gastroenterology; 2016 Jul; 151(1):51-69.e14. PubMed ID: 27102658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
    Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
    World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori eradication therapy.
    Suzuki H; Nishizawa T; Hibi T
    Future Microbiol; 2010 Apr; 5(4):639-48. PubMed ID: 20353303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.
    Luther J; Higgins PD; Schoenfeld PS; Moayyedi P; Vakil N; Chey WD
    Am J Gastroenterol; 2010 Jan; 105(1):65-73. PubMed ID: 19755966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection.
    Gisbert JP; Perez-Aisa A; Rodrigo L; Molina-Infante J; Modolell I; Bermejo F; Castro-Fernández M; Antón R; Sacristán B; Cosme A; Barrio J; Harb Y; Gonzalez-Barcenas M; Fernandez-Bermejo M; Algaba A; Marín AC; McNicholl AG;
    Dig Dis Sci; 2014 Feb; 59(2):383-9. PubMed ID: 24126798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel and Effective Therapeutic Regimens for
    Hu Y; Zhu Y; Lu NH
    Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
    [No Abstract]   [Full Text] [Related]  

  • 11. The second Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of Helicobacter pylori infection in adult patients in Ireland.
    Smith SM; Boyle B; Buckley M; Costigan C; Doyle M; Farrell R; Ismail MS; Kevans D; Nugent S; O'Connor A; O'Morain C; Parihar V; Ryan C; McNamara D
    Eur J Gastroenterol Hepatol; 2024 Aug; 36(8):1000-1009. PubMed ID: 38829956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-line rescue treatment of
    Lin TF; Hsu PI
    World J Gastroenterol; 2018 Oct; 24(40):4548-4553. PubMed ID: 30386104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.
    Dehghani SM; Erjaee A; Imanieh MH; Haghighat M
    Dig Dis Sci; 2009 Aug; 54(8):1720-4. PubMed ID: 19005755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.
    Zhang W; Chen Q; Liang X; Liu W; Xiao S; Graham DY; Lu H
    Gut; 2015 Nov; 64(11):1715-20. PubMed ID: 26338726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.
    Tsay FW; Wu DC; Yu HC; Kao SS; Lin KH; Cheng JS; Wang HM; Chen WC; Sun WC; Tsai KW; Hsu PI
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
    Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
    Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for
    Bang CS; Lim H; Jeong HM; Shin WG; Choi JH; Soh JS; Kang HS; Yang YJ; Hong JT; Shin SP; Suk KT; Lee JJ; Baik GH; Kim DJ
    Gut Microbes; 2020 Sep; 11(5):1314-1323. PubMed ID: 32362221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world practice of Helicobacter pylori management: A survey among physicians in Southeast Asia.
    Quach DT; Vilaichone RK; Luu MN; Lee YY; Ang TL; Miftahussurur M; Aye TT; Basir DN; Vutha K; Vannarath S; Sollano JD; Mahachai V
    Helicobacter; 2023 Dec; 28(6):e13018. PubMed ID: 37634226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
    Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
    Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics.
    Fallone CA; Moss SF; Malfertheiner P
    Gastroenterology; 2019 Jul; 157(1):44-53. PubMed ID: 30998990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.